Treatment of Thrombotic Antiphospholipid Syndrome: The Rationale of Current Management—An Insight into Future Approaches

<div>Flow-diagram of the therapeutic approach to thrombotic APS. aPL: antiphospholipid antibodies; CAPS: catastrophic antiphospholipid syndrome; LDASA: low-dose aspirin; PE: plasma exchange; HCQ: hydroxychloroquine.</div>

Journal of Immunology Research

fig2

Figure 2

Figure 2: Treatment of Thrombotic Antiphospholipid Syndrome: The Rationale of Current Management—An Insight into Future Approaches 